End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
116.1 BDT | -0.43% | -1.36% | -20.59% |
Mar. 04 | Beximco names Iqbal Ahmed as managing director | AN |
Jan. 30 | Beximco Pharmaceuticals to strengthen portfolio as interim profit up | AN |
Sales 2024 * | 44.55B 409M | Sales 2025 * | 50.49B 463M | Capitalization | 51.79B 475M |
---|---|---|---|---|---|
Net income 2024 * | 5.13B 47.09M | Net income 2025 * | 6B 55.06M | EV / Sales 2024 * | 1.3 x |
Net Debt 2024 * | 5.99B 54.99M | Net Debt 2025 * | 884M 8.11M | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
9.44
x | P/E ratio 2025 * |
7.69
x | Employees | 5,700 |
Yield 2024 * |
3.45% | Yield 2025 * |
4.31% | Free-Float | 76.68% |
1 day | -0.43% | ||
1 week | -1.36% | ||
Current month | -0.26% | ||
1 month | -1.19% | ||
3 months | -8.15% | ||
6 months | -20.59% | ||
Current year | -20.59% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 116.1 | -0.43% | 144,223 |
24-04-24 | 116.6 | -2.02% | 91,895 |
24-04-23 | 119 | -0.17% | 124,390 |
24-04-22 | 119.2 | +0.25% | 190,856 |
24-04-21 | 118.9 | +1.02% | 150,959 |
End-of-day quote Dhaka S.E., April 24, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 472M | |
+24.84% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.36% | 233B | |
+5.54% | 201B | |
-10.14% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- BXPHARMA Stock